Chikazawa Hirotaka | Kanagawa Laboratories Clinical Research & Product Development Division Bristol-myers Squibb K.k.

スポンサーリンク

概要

• CHIKAZAWA Hirotakaの詳細を見る
• 同名の論文著者
• Kanagawa Laboratories Clinical Research & Product Development Division Bristol-myers Squibb K.k.の論文著者

関連著者

• Chikazawa Hirotaka

  Kanagawa Laboratories Clinical Research & Product Development Division Bristol-myers Squibb K.k.

• CHIKAZAWA Hirotaka

  Kanagawa Laboratories, Bristol-Myers Squibb K.K.,

• YAMORI Takao

  Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea

• Yamori Takao

  Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer

• Takahashi N

  Faculty Of Pharmaceutical Sciences Okayama University

• SATO Shigeo

  Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Re

• Kadota Toshihito

  Kanagawa Laboratories Clinical Research & Product Development Division Bristol-myers Squibb K. K

• Tanaka M

  Otsuka Pharmaceutical Co. Ltd. Tokushima Jpn

• TANAKA Makoto

  Kanagawa Laboratories, Bristol-Myers Squibb K.K.,

• KUWAHARA Etsuhisa

  Kanagawa Laboratories, Bristol-Myers Squibb K.K.,

• SHIMIZU Takayoshi

  Kanagawa Laboratories, Bristol-Myers Squibb K.K.,

• HISADA Shinji

  Kanagawa Laboratories, Bristol-Myers Squibb K.K.,

• TAKAHASHI Norimitsu

  Kanagawa Laboratories, Bristol-Myers Squibb K.K.,

• Hisada Shinji

  Kanagawa Laboratories Bristol-myers Squibb K.k.

• Fujimoto Shuichi

  Division Of Chemotherapy Chiba Cancer Center Research Institute

• Shimizu Takayoshi

  Kanagawa Laboratories Bristol-myers Squibb K.k.

• Kuwahara E

  Kanagawa Laboratories Bristol-myers Squibb K.k.

• Chikazawa H

  Kanagawa Laboratories Bristol-myers Squibb K.k.

• Tanaka M

  Kanagawa Laboratories Bristol-myers Squibb K.k.

• Sato Shigeo

  Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese

• Yamori Takao

  Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese

• CHIKAZAWA Hirotaka

  Kanagawa Laboratories, Clinical Research & Product Development Division, Bristol-Myers Squibb K. K.

もっと見る 閉じる

著作論文

• Rectal Absorption of [Bis (acetato) ammine dichloro (cyclohexylamine)platinum(IV)](BMS-182751), a New Anti-tumor Agent, in Rats
• Anti-tumor Efficacy of Paclitaxel against Human Lung Cancer Xenografts
• Schedule-dependent and -independent Antitumor Activity of Paclitaxel-based Combination Chemotherapy against M-109 Murine Lung Carcinoma in vivo

スポンサーリンク